| A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women (NCT00858078) | National Cancer Institute (NCI) | 2011-06-21 |
| Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery (NCT01386385) | National Cancer Institute (NCI) | 2011-06-20 |
| Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction (NCT01366144) | National Cancer Institute (NCI) | 2011-06-20 |
| Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma (NCT01369875) | National Cancer Institute (NCI) | 2011-06-17 |
| Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery (NCT01274338) | National Cancer Institute (NCI) | 2011-06-17 |
| CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors (NCT01386502) | National Cancer Institute (NCI) | 2011-06-15 |
| Livestock Contact and MRSA in Rural Areas (NCT01375621) | National Cancer Institute (NCI) | 2011-06-01 |
| Follow-up Study of Late Effects of Periconceptional Folic Acid in Mothers and Offspring in the Community Intervention Program Population: The Chinese Children and Families Study (NCT01365975) | National Cancer Institute (NCI) | 2011-06-01 |
| Resveratrol in Postmenopausal Women With High Body Mass Index (NCT01370889) | National Cancer Institute (NCI) | 2011-06-01 |
| Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma (NCT01418495) | National Cancer Institute (NCI) | 2011-05-26 |
| Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies (NCT01364051) | National Cancer Institute (NCI) | 2011-05-25 |
| Lapatinib in Stage IV Melanoma With ERBB4 Mutations (NCT01264081) | National Cancer Institute (NCI) | 2011-05-20 |
| SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma (NCT01362790) | National Cancer Institute (NCI) | 2011-05-11 |
| Evaluation of Molecular Markers in Adrenal Tumors (NCT01348698) | National Cancer Institute (NCI) | 2011-05-04 |
| Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer (NCT01351909) | National Cancer Institute (NCI) | 2011-05-02 |
| Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia (NCT01361464) | National Cancer Institute (NCI) | 2011-05-01 |
| Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma (NCT01369888) | National Cancer Institute (NCI) | 2011-05-01 |
| Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma (NCT01340794) | National Cancer Institute (NCI) | 2011-05-01 |
| Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma (NCT01286272) | National Cancer Institute (NCI) | 2011-04-28 |
| Carboplatin and Bevacizumab for Recurrent Ependymoma (NCT01295944) | National Cancer Institute (NCI) | 2011-04-27 |
| PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment (NCT01581541) | National Cancer Institute (NCI) | 2011-04-26 |
| MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer (NCT01344031) | National Cancer Institute (NCI) | 2011-04-21 |
| Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation (NCT01338987) | National Cancer Institute (NCI) | 2011-04-19 |
| Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal (NCT01341496) | National Cancer Institute (NCI) | 2011-04-18 |
| Evaluation of Cancer Care Coordination in the National Cancer Institutes Community Cancer Center Programs (NCT01346280) | National Cancer Institute (NCI) | 2011-04-16 |
| Drosophila-generated CTL (NCT01271907) | National Cancer Institute (NCI) | 2011-04-15 |
| Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia (NCT01253070) | National Cancer Institute (NCI) | 2011-04-01 |
| Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT01349933) | National Cancer Institute (NCI) | 2011-04-01 |
| Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer (NCT01342770) | National Cancer Institute (NCI) | 2011-04-01 |
| Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT01349972) | National Cancer Institute (NCI) | 2011-04-01 |
| MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery (NCT01425879) | National Cancer Institute (NCI) | 2011-04-01 |
| A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer (NCT01283035) | National Cancer Institute (NCI) | 2011-04-01 |
| MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer (NCT01319539) | National Cancer Institute (NCI) | 2011-04-01 |
| Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy (NCT01339000) | National Cancer Institute (NCI) | 2011-04-01 |
| Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation (NCT01326728) | National Cancer Institute (NCI) | 2011-03-30 |
| Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer (NCT01327781) | National Cancer Institute (NCI) | 2011-03-25 |
| Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI... (NCT01319565) | National Cancer Institute (NCI) | 2011-03-24 |
| Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer (NCT01305213) | National Cancer Institute (NCI) | 2011-03-21 |
| Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer (NCT01324141) | National Cancer Institute (NCI) | 2011-03-18 |
| Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer (NCT01251861) | National Cancer Institute (NCI) | 2011-03-17 |
| Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer (NCT01281852) | National Cancer Institute (NCI) | 2011-03-14 |
| Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum (NCT01313429) | National Cancer Institute (NCI) | 2011-03-04 |
| AZD8055 for Adults With Recurrent Gliomas (NCT01316809) | National Cancer Institute (NCI) | 2011-03-04 |
| Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer (NCT01313442) | National Cancer Institute (NCI) | 2011-03-02 |
| TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma (NCT01328574) | National Cancer Institute (NCI) | 2011-03-01 |
| Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI (NCT01312467) | National Cancer Institute (NCI) | 2011-03-01 |
| Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer (NCT01307631) | National Cancer Institute (NCI) | 2011-03-01 |
| MK-2206 and AZD6244 in Patients With Advanced Colorectal Carcinoma (NCT01333475) | National Cancer Institute (NCI) | 2011-03-01 |
| Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer (NCT01277757) | National Cancer Institute (NCI) | 2011-03-01 |
| Endoxifen in Adults With Hormone Receptor Positive Solid Tumors (NCT01273168) | National Cancer Institute (NCI) | 2011-03-01 |
| Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer (NCT01272037) | National Cancer Institute (NCI) | 2011-02-28 |
| Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma (NCT01303341) | National Cancer Institute (NCI) | 2011-02-18 |
| Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer (NCT01196390) | National Cancer Institute (NCI) | 2011-02-14 |
| DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study (NCT01247597) | National Cancer Institute (NCI) | 2011-02-13 |
| Sorafenib and TRC105 in Hepatocellular Cancer (NCT01306058) | National Cancer Institute (NCI) | 2011-02-11 |
| Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy (NCT01295515) | National Cancer Institute (NCI) | 2011-02-11 |
| Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer (NCT01254617) | National Cancer Institute (NCI) | 2011-02-10 |
| High-Dose or Low-Dose Vorinostat in Combination With Carboplatin or Paclitaxel in Treating Patients With Advanced Solid Tumors (NCT01281176) | National Cancer Institute (NCI) | 2011-02-09 |
| Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer (NCT01275677) | National Cancer Institute (NCI) | 2011-02-08 |
| Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies (NCT01306045) | National Cancer Institute (NCI) | 2011-02-08 |
| Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers (NCT01237067) | National Cancer Institute (NCI) | 2011-02-07 |
| MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy (NCT01294306) | National Cancer Institute (NCI) | 2011-02-01 |
| Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye (NCT00329641) | National Cancer Institute (NCI) | 2011-02-01 |
| Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma (NCT01307618) | National Cancer Institute (NCI) | 2011-02-01 |
| Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer (NCT01266447) | National Cancer Institute (NCI) | 2011-02-01 |
| A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediatric Patients With Solid Tumors and Leukemias (NCT01287104) | National Cancer Institute (NCI) | 2011-01-29 |
| Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer (NCT01239342) | National Cancer Institute (NCI) | 2011-01-27 |
| A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) (NCT01240590) | National Cancer Institute (NCI) | 2011-01-26 |
| Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer (NCT01296139) | National Cancer Institute (NCI) | 2011-01-26 |
| Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma (NCT01236560) | National Cancer Institute (NCI) | 2011-01-26 |
| Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial (NCT01294358) | National Cancer Institute (NCI) | 2011-01-26 |
| Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma (NCT01169337) | National Cancer Institute (NCI) | 2011-01-24 |
| Message Testing for Tobacco-Related Corrective Statements (NCT01282008) | National Cancer Institute (NCI) | 2011-01-21 |
| Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT01249430) | National Cancer Institute (NCI) | 2011-01-20 |
| Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery (NCT01258855) | National Cancer Institute (NCI) | 2011-01-18 |
| (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas (NCT01281982) | National Cancer Institute (NCI) | 2011-01-13 |
| Phase II ABT-888 With Cyclophosphamide (NCT01306032) | National Cancer Institute (NCI) | 2011-01-12 |
| Azacitidine in Treating Patients With Previously Treated Advanced Non-Small Cell Lung Cancer (NCT01281124) | National Cancer Institute (NCI) | 2011-01-12 |
| Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction (NCT01273155) | National Cancer Institute (NCI) | 2011-01-10 |
| AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer (NCT01287130) | National Cancer Institute (NCI) | 2011-01-07 |
| MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer (NCT01263145) | National Cancer Institute (NCI) | 2011-01-05 |
| Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility Genes (NCT01200680) | National Cancer Institute (NCI) | 2011-01-02 |
| Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer (NCT01247571) | National Cancer Institute (NCI) | 2011-01-01 |
| Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer (NCT01281163) | National Cancer Institute (NCI) | 2011-01-01 |
| Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma (NCT01281865) | National Cancer Institute (NCI) | 2011-01-01 |
| Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer (NCT01264432) | National Cancer Institute (NCI) | 2011-01-01 |
| Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer (NCT01260701) | National Cancer Institute (NCI) | 2011-01-01 |
| MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia (NCT01231919) | National Cancer Institute (NCI) | 2011-01-01 |
| Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT01281150) | National Cancer Institute (NCI) | 2011-01-01 |
| Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer (NCT01282333) | National Cancer Institute (NCI) | 2011-01-01 |
| Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery (NCT01134614) | National Cancer Institute (NCI) | 2010-12-28 |
| Thyroid Cancer Among Chornobyl Clean-up Workers in Ukraine: Pilot Study (NCT01265381) | National Cancer Institute (NCI) | 2010-12-22 |
| Vismodegib in Treating Patients With Advanced Chondrosarcomas (NCT01267955) | National Cancer Institute (NCI) | 2010-12-21 |
| Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (NCT01256398) | National Cancer Institute (NCI) | 2010-12-14 |
| Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT01238211) | National Cancer Institute (NCI) | 2010-12-14 |
| Environmental and Genetic Determinants of NPC (NCT01257100) | National Cancer Institute (NCI) | 2010-12-08 |
| Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas (NCT01143545) | National Cancer Institute (NCI) | 2010-12-07 |
| Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT01199263) | National Cancer Institute (NCI) | 2010-12-06 |
| Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors (NCT01259479) | National Cancer Institute (NCI) | 2010-12-03 |
| Saracatinib in Treating Patients With Prostate Cancer (NCT01267266) | National Cancer Institute (NCI) | 2010-12-01 |